External broker reports(aggregated public sources), CMB International

CMB International

External broker reports(aggregated public sources)

Incorporated in Hong Kong, supported by the mainland and targeting in global market, CMB International Capital Corporation Limited (“CMBI”) is an integrated financial institution providing comprehensive and professional services. As a wholly-owned subsidiary of China Merchants Bank ("CMB"), by leveraging on the Group’s synergy and coordination in domestic and overseas markets, as well as CMB’s strong resources and outstanding social reputation, CMBI and its subsidiaries have been actively implementing diversified business strategies and set up an overall layout of main business segments including Corporate Finance, Asset Management, Wealth Management, Global Markets and Structured Finance, etc. Adhering to the philosophy of “being clients oriented and increasing our own values by the way of creating value for clients”, CMBI endeavors to provide quality and integrated financial services to institutional, corporate and individual customers both domestic and overseas including Hong Kong IPO sponsorship and underwriting, share placement and rights issue for listed companies, financial advisors, bonds issuance services, asset management, direct investment, wealth management, equity sales and trading, etc.

Equity Bottom-Up

<div><div><div><div><ul><li>Initiate at BUY. ClouDr is a pioneer and leader in China’s digital healthcare industry with a focus on chronic condition management in the scenarios of hospitals, pharmacies and individual users.</li><li>According to F&amp;S, the Company is the largest digital chronic condition management solution provider in China in terms of numbers of SaaS installations in hospitals and pharmacies as of 2021.</li><li><div><div><div><p>Big market potential of digital chronic condition management in China.</p></div></div></div></li></ul></div></div></div></div><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Initiate at BUY. ClouDr is a pioneer and leader in China’s digital healthcare industry with a focus on chronic condition management in the scenarios of hospitals, pharmacies and individual users.According to F&amp;S, the Company is the largest digital chronic condition management solution provider in China in terms of numbers of SaaS installations in hospitals and pharmacies as of 2021.Big market potential of digital chronic condition management in China.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

ClouDr (9955 HK) – Digitalizing the chronic condition management market in China

China

ClouDr Group Limited is a China-based investment holding company that provides medical services and products. It offers medical supplies, SaaS solutions to hospitals and pharmacies, and digital marketing services to pharmaceutical companies, alongside online consultations and prescriptions for patients. The company was founded in 2014 and is headquartered in Hangzhou, China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ClouDr Group (9955 HK)

ClouDr (9955 HK) – Digitalizing the chronic condition management market in China

ClouDr is a pioneer and leader in China’s digital healthcare industry with a focus on chronic condition management in the scenarios of hospitals,...

CMB International

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)